Progyny Analyst Price Targets - Benzinga

Progyny Inc

PGNYNASDAQ

Trade with Public

Trade with Public

$27.93

0.100.36%

Ult. Agg.: Oct 9, 4:00 PM

$27.93

0.100.36%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Progyny Analyst Price Targets - Benzinga

Progyny Analyst Price Targets

Wall Street analyst price targets and consensus rating for Progyny (PGNY).

Price Target Range — 12 Quarters

Analyst Consensus — 12 Analysts

1S.Buy

9Buy

2Hold

Consensus RatingOverweight# Analysts12Avg. Consensus PT$31Upside to Avg. PT+11.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 30, 2026	Wells Fargo	Stan Berenshteyn	Initiate	Overweight	$37
Sep 8, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$31→$33
Aug 21, 2026	JP Morgan	Lisa Gill	PT Raise	Neutral	$27→$30
Aug 20, 2026	Wells Fargo	Stan Berenshteyn	Initiate	Overweight	$37
Aug 13, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$33→$36
Aug 12, 2026	Barclays	Peter Warendorf	PT Cut	Equal-Weight	$34→$30
Jul 28, 2026	Barclays	Peter Warendorf	Downgrade	Overweight→Equal-Weight	$27→$34
Jul 24, 2026	BTIG	David Larsen	PT Raise	Buy	$30→$40
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$30→$36
Jul 13, 2026	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$30→$35
Jun 22, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$30→$33
Jun 2, 2026	B of A Securities	Michael Cherny	PT Raise	Buy	$29→$31
May 19, 2026	Canaccord Genuity	Richard Close	Upgrade	Hold→Buy	$19→$30
May 18, 2026	Barclays	Glen Santangelo	PT Raise	Overweight	$23→$27
May 11, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$28→$30
May 11, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$30→$31
Mar 20, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$29→$23
Mar 11, 2026	Canaccord Genuity	Richard Close	PT Cut	Hold	$26→$19
Mar 5, 2026	BTIG	David Larsen	PT Cut	Buy	$35→$30
Mar 2, 2026	Keybanc	Scott Schoenhaus	PT Cut	Overweight	$32→$28

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33

Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $31 to $33.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30

JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $27 to $30.

Benzinga Newsdesk

PRO
Wells Fargo Initiates Coverage On Progyny with Overweight Rating, Announces Price Target of $37

Wells Fargo analyst Stan Berenshteyn initiates coverage on Progyny (NASDAQ:PGNY) with a Overweight rating and announces Price Target of $37.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Progyny, Raises Price Target to $36

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $33 to $36.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30

Barclays analyst Peter Warendorf maintains Progyny (NASDAQ:PGNY) with a Equal-Weight and lowers the price target from $34 to $30.

Benzinga Newsdesk

This Clorox Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Wall Street analysts change outlook on top stocks. See upgrade, downgrade, and initiation changes on our analyst ratings page. CLX stock has mixed reviews.

Avi Kapoor